4551Torii Pharmaceutical4551 info
$26.29info0.67%24h
Global rank9263
Market cap$738.64M
Change 7d4.31%
YTD Performance5.19%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Torii Pharmaceutical (4551) Stock Overview

    Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; CORECTIM, a topical janus kinase (JAK) inhibitor; and allergen immunotherapy tablets comprising CEDARCURE and MITICURE. In addition, it is engaged in real estate rental business. The company markets its products primarily through medical representatives for medical professionals. The company has a collaboaration with ALK-Abelló A/S to develop, market and distribute ALK's allergy immunotherapy tablet for the treatment of grass pollen allergy. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

    4551 Stock Information

    Symbol
    4551
    Address
    Torii Nihonbashi Bldg.Tokyo, 103-8439Japan
    Founded
    -
    Trading hours
    -
    Website
    https://www.torii.co.jp
    Country
    🇯🇵 Japan
    Phone Number
    81 3 3231 6811

    Torii Pharmaceutical (4551) Price Chart

    -
    Value:-

    Torii Pharmaceutical Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $26.29
    N/A
    Market Cap
    $738.64M
    N/A
    Shares Outstanding
    28.10M
    N/A
    Employees
    563.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org